ImmunityBio, Inc. IBRX Treasury stock, shares (in shares)
Treasury stock, shares (in shares) at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s treasury stock, shares (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s treasury stock, shares (in shares)?
- ImmunityBio, Inc. (IBRX) reported treasury stock, shares (in shares) of $163.8K in Q1 2026.
- How has ImmunityBio, Inc.'s treasury stock, shares (in shares) changed year-over-year?
- ImmunityBio, Inc.'s treasury stock, shares (in shares) decreased by 0.0% year-over-year, from $163.8K to $163.8K.
- What is the long-term trend for ImmunityBio, Inc.'s treasury stock, shares (in shares)?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s treasury stock, shares (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $163.8K to $163.8K.